AKT1 and acute lymphoblastic leukemia: Consistently, the mutational loss of the oncosuppressor PTEN results in the constitutive activation of AKT signal that stabilizes Myc by inhibiting its GSK-3β-dependent proteasomal degradation [105], making T-ALL cells resistant to Notch pharmacological inhibition [104].